Salud financiera de hoja de balance de C.I. MedicalLtd

Salud financiera controles de criterios 2/6

C.I. MedicalLtd tiene unos fondos propios totales de ¥20.1B y una deuda total de ¥17.2B, lo que sitúa su ratio deuda/fondos propios en 85.4%. Sus activos y pasivos totales son ¥41.5B y ¥21.4B respectivamente. C.I. MedicalLtd El EBIT de la empresa es de ¥3.0B, por lo que su ratio de cobertura de intereses es de -149.6. Su tesorería e inversiones a corto plazo ascienden a ¥1.8B.

Información clave

85.4%

Ratio deuda-patrimonio

JP¥17.19b

Deuda

Ratio de cobertura de intereses	-149.6x
Efectivo	JP¥1.80b
Patrimonio	JP¥20.14b
Total pasivo	JP¥21.37b
Activos totales	JP¥41.51b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

Feb 18

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Jan 31

Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?

Jan 13

Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?

Dec 26

Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?

Dec 08

Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?

Nov 20

The C.I. MedicalLtd (TYO:3540) Share Price Is Up 60% And Shareholders Are Holding On

Jul 07

Análisis de la situación financiera

Pasivos a corto plazo: 3540Los activos a corto plazo (¥17.8B) no cubren sus pasivos a corto plazo (¥20.9B).

Pasivo a largo plazo: 3540Los activos a corto plazo (¥17.8B) superan a sus pasivos a largo plazo (¥499.0M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de 3540 (75.8%) se considera alta.

Reducción de la deuda: 3540ha pasado de 0% a 85.4% en los últimos 5 años.

Cobertura de la deuda: 3540's operating cash flow es negativo, por lo que la deuda no está bien cubierta.

Cobertura de intereses: 3540 gana más intereses de los que paga, por lo que la cobertura del pago de intereses no es preocupante.

Hoja de balance

Descubre empresas con salud financiera

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Salud financiera de hoja de balance de C.I. MedicalLtd

Salud financiera controles de criterios 2/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 26, 2024

Full year 2023 earnings released: EPS: JP¥208 (vs JP¥252 in FY 2022)

C.I. Medical Co.,Ltd. to Report Fiscal Year 2023 Results on Feb 13, 2024

Upcoming dividend of JP¥25.00 per share at 0.6% yield

Investor sentiment improves as stock rises 15%

New major risk - Financial position

Third quarter 2023 earnings released: EPS: JP¥51.29 (vs JP¥57.01 in 3Q 2022)

C.I. Medical Co.,Ltd. to Report Q3, 2023 Results on Nov 14, 2023

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: JP¥70.50 (vs JP¥65.91 in 2Q 2022)

C.I. Medical Co.,Ltd. to Report Q2, 2023 Results on Aug 08, 2023

First quarter 2023 earnings released: EPS: JP¥52.10 (vs JP¥86.91 in 1Q 2022)

Full year 2022 earnings: EPS misses analyst expectations

Now 23% undervalued after recent price drop

Consensus EPS estimates fall by 16%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

C.I. Medical Co.,Ltd. to Report Fiscal Year 2022 Results on Feb 14, 2023

Upcoming dividend of JP¥28.50 per share

Third quarter 2022 earnings released: EPS: JP¥57.01 (vs JP¥65.91 in 3Q 2021)

Third quarter 2022 earnings released: EPS: JP¥56.99 (vs JP¥65.91 in 3Q 2021)

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Naiki Shiken Ltd. from Yuichi Naiki and Yuriko Naiki.

C.I. Medical Co.,Ltd. to Report Q3, 2022 Results on Nov 08, 2022

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Sakura Dental Laboratory from Akira Ochi and Katsumi Ochi.

Second quarter 2022 earnings released: EPS: JP¥65.90 (vs JP¥67.61 in 2Q 2021)

C.I. Medical Co.,Ltd. to Report Q2, 2022 Results on Aug 09, 2022

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to JP¥4,300

C.I. Medical Co.,Ltd. to Report Q1, 2022 Results on May 10, 2022

Investor sentiment improved over the past week

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 24, 2022

Full year 2021 earnings: EPS misses analyst expectations

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased to JP¥5,300

Third quarter 2021 earnings released: EPS JP¥65.89 (vs JP¥81.10 in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥67.61 (vs JP¥65.10 in 2Q 2020)

Investor sentiment deteriorated over the past week

Looop Inc. agreed to acquire 60% stake in Niigata Prefectural Electric Power Co., Ltd. and Yotsuba Electric Power Co., Ltd. from C.I. Medical Co.,Ltd. (JASDAQ:3540).

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥87.40 (vs JP¥48.50 in 1Q 2020)

Here's Why We Think C.I. MedicalLtd (TYO:3540) Is Well Worth Watching

Returns on Capital Paint A Bright Future For C.I. MedicalLtd (TYO:3540)

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Investor sentiment improved over the past week

Should You Investigate C.I. Medical Co.,Ltd. (TYO:3540) At JP¥5,450?

New 90-day low: JP¥5,490

Analysts increase EPS estimates to JP¥320

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

C.I. Medical Co.,Ltd. (JASDAQ:3540) acquired 22.4% stake in Fuji Dental Lab Co., Ltd.

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Revenue and earnings beat expectations

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Yosuke Oda Kaki and Keisuke Hori agreed to acquire an additional 60% stake in One Recto Holdings Co., Ltd. from C.I. Medical Co.,Ltd. (JASDAQ:3540).

New 90-day low: JP¥5,900

Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?

C.I. Medical Co.,Ltd. to Report Fiscal Year 2020 Results on Feb 21, 2021

Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?

Upcoming Dividend of JP¥15.00 Per Share

New 90-day low: JP¥6,150

Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?

New 90-day low: JP¥6,520

Analysts increase EPS estimates to JP¥251

Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?

Third quarter 2020 earnings released: EPS JP¥81.10

Revenue and earnings beat expectations

C.I. Medical Co.,Ltd. (JASDAQ:3540) reached an agreement to acquire 60% stake in Niigata Prefectural Electric Power Co., Ltd. from Takashi Kakuya, Chairman and Director of Niigata Prefectural Electric Power Co., Ltd.

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS JP¥81.10

New 90-day high: JP¥8,810

C.I. Medical Co.,Ltd. to Report Q3, 2020 Results on Nov 10, 2020

New 90-day high - JP¥7,770

New 90-day high - JP¥5,630

Earnings released

C.I. Medical Co.,Ltd. (JASDAQ:3540) agreed to acquire a 60% stake in Onelect Holdings Co, Ltd. from Yosuke Odagaki and Keisuke Hori.

The C.I. MedicalLtd (TYO:3540) Share Price Is Up 60% And Shareholders Are Holding On